The First Treatment for Schizophrenia's Negative Symptoms Is a Smartphone App

Click Therapeutics' Motivista became the first FDA-authorized treatment for the negative symptoms of schizophrenia, delivered as a 16-week smartphone program alongside standard care. In its phase 3 trial, patients improved 62 percent more than those using a control app.